Christopher Rivet has successfully married two powerful bioengineering technologies to develop a new method for delivering drugs directly to an injury site and jumpstarting the process of tissue regeneration. His innovation could be an important new tool in preventing paralysis resulting from spinal cord trauma, cancer, diabetes, or a host of other diseases.
Rivet, a doctoral student in the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, is one of three finalists for the 2012 $30,000 Lemelson-MIT Rensselaer Student Prize. A public ceremony announcing this year’s winner will be held at 6:45 p.m. on Wednesday, March 7, in the auditorium of the Rensselaer Center for Biotechnology and Interdisciplinary Studies. For more information on the ceremony visit: http://www.eng.rpi.edu/lemelson
Rivet’s project is titled “A Hydrogel and Electrospun Fiber Composite Material,” and his faculty adviser is Ryan Gilbert, assistant professor of biomedical engineering at Rensselaer.
Sadly, there is no shortage of situations that lead to a loss of functioning tissue and, in turn, paralysis. These circumstances can range from the surgical removal of a tumor, to untreated bedsores, to a spinal cord injury stemming from a gunshot wound or traffic accident. All of these situations require action first to stop the progression of the injury, and secondly to restore function to the damaged tissue. However, there is currently no treatment, short of receiving a transplant from a donor, to simultaneously pursue both goals and more effectively mitigate the onset of paralysis.
Rivet’s patent-pending invention pairs electrospun fibers with hydrogels to help solve this important societal need. He has developed a new way to disperse nanoscopic electrospun fibers, which can prompt and guide tissue regeneration, within injectable, drug-infused hydrogels. The result is an advanced biomaterial that can mimic and serve as a temporary replacement for living tissue.
For example, potential target could be a patient who had a large bone tumor removed, leaving behind a hole that is too large for the body to recover from on its own. The surgeon may elect to use a hydrogel. Injected as a liquid, the hydrogel would firm up and fill in the unique shape of the void. Hydrogels can be treated with different drugs to help stop progression of the injury, and the gels can be tuned to match the mechanical properties of the tissue their replacing. However, hydrogels cannot carry the appropriate chemical cues to guide regenerative nerve cells into and out of the injury site. This means hydrogels alone are not a winning strategy for combating the onset of paralysis.
Rivet has incorporated electrospun fibers, which are spun from polymer and can carry guidance cues and promote functional recovery, into hydrogels. The end result is a complex system that can deliver multiple drugs as well as the necessary guidance cues to coax nerve cells through the injury site and kick start the process of regeneration. As the patient’s body tissue regenerates, the hydrogels and electrospun fibers simply dissolve harmlessly. Rivet’s system is also highly adaptable, as different electrospun fibers can be matched with various hydrogels to achieve specific goals.
When not in the lab or classroom, Rivet enjoys spending time outdoors. If he’s not skiing, cycling, or hiking, you can probably find him on the lake fishing. At home in Grand Blanc, Mich., Rivet’s family and friends are rooting for him to win the $30,000 Lemelson-MIT Rensselaer Student Prize. His mother is a high school math and science teacher and his father works for the United Auto Workers labor union. Rivet’s older sister is a laboratory manager at Kettering University.
Rivet was curious and creative as a young student, and he strives to foster those virtues in others. He is an active mentor in local elementary schools and high schools, sparking the interest of students and encouraging them to seek out opportunities to study and work in the fields of science, technology, engineering, or mathematics. He also mentors several undergraduate students at Rensselaer.
Rivet received his bachelor’s degree in biomedical engineering from Michigan Technological University, and his master’s degrees in biomedical engineering from Wayne State University. He recently won a 2012 Endeavor Research Fellowship from the Australian Department of Education to fund a six-month research program at Monash University in Melbourne, Australia.
About the $30,000 Lemelson-MIT Rensselaer Student Prize
The $30,000 Lemelson-MIT Rensselaer Student Prize is funded through a partnership with the Lemelson-MIT Program, which has awarded the $30,000 Lemelson-MIT Student Prize to outstanding student inventors at MIT since 1995.ABOUT THE LEMELSON-MIT PROGRAM
Jerome H. Lemelson, one of U.S. history’s most prolific inventors, and his wife, Dorothy, founded the Lemelson-MIT Program at the Massachusetts Institute of Technology in 1994. It is funded by The Lemelson Foundation and administered by the School of Engineering. The Foundation sparks, sustains, and celebrates innovation and the inventive spirit. It supports projects in the U.S. and developing countries that nurture innovators and unleash invention to advance economic, social, and environmentally sustainable development. To date The Lemelson Foundation has donated or committed more than U.S. $150 million in support of its mission. http://web.mit.edu/invent/
For information on the $30,000 Lemelson-MIT Rensselaer Student Prize, visit:• Student Innovator Uses Sound Waves, T-Rays for Safer Detection of Bombs and Other Dangerous Materials
Benjamin Clough’s invention increases distance between first responders and potential threats http://news.rpi.edu/update.do?artcenterkey=2840• Helping Hydrogen: Student Inventor Tackles Challenge of Hydrogen Storage
http://news.rpi.edu/update.do?artcenterkey=2690• Student Developer of Versatile “G-gels” Wins $30,000 Lemelson-Rensselaer Prize
http://news.rpi.edu/update.do?artcenterkey=2538• Student Develops New LED, Wins $30,000 Lemelson-Rensselaer Prize
Michael Mullaney | Newswise Science News
Further reports about: > Eye Injuries > Ferchau Engineering > Gates Foundation > Hydrogel > Hydrogen > LED > Lemelson-MIT Prize > Lemelson-Rensselaer Prize > Polytechnic > Tissue Engineering > Untreatable > biomedical engineering > medical engineering > nerve cell > spinal cord > tissue regeneration
Discovery of genes involved in the biosynthesis of antidepressant
09.12.2019 | Leibniz Institute of Plant Genetics and Crop Plant Research
Scientists have spotted new compounds with herbicidal potential from sea fungus
09.12.2019 | Far Eastern Federal University
Using a clever technique that causes unruly crystals of iron selenide to snap into alignment, Rice University physicists have drawn a detailed map that reveals...
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
Research from a leading international expert on the health of the Great Lakes suggests that the growing intensity and scale of pollution from plastics poses serious risks to human health and will continue to have profound consequences on the ecosystem.
In an article published this month in the Journal of Waste Resources and Recycling, Gail Krantzberg, a professor in the Booth School of Engineering Practice...
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
09.12.2019 | Earth Sciences
09.12.2019 | Information Technology
09.12.2019 | Life Sciences